The aim of the present study was to evaluate the activity of the LHRH-agonist (Goserelin), in hormone-dependent breast cancer in dogs. The results showed that goserelin is effective in the treatment of hormone-dependent canine breast cancer, specifically acting on the hypothalamus-pituitary-ovary axis.
Goserelin is effective in the treatment of hormone-dependent canine mammary tumors / Lombardi, Pietro; Avallone, Luigi; Volpe, P.; Tortora, Gennaro; D'Angelo, Danila; Scarfò, M.; Florio, Salvatore. - STAMPA. - 20(1):(1997), pp. 168-169. (Intervento presentato al convegno 7th European Association for Veterinary Pharmacology and Therapeutics tenutosi a Madrid (SPAIN) nel 6-10 july 1997).
Goserelin is effective in the treatment of hormone-dependent canine mammary tumors
LOMBARDI, PIETRO;AVALLONE, LUIGI;TORTORA, GENNARO;D'ANGELO, DANILA;FLORIO, SALVATORE
1997
Abstract
The aim of the present study was to evaluate the activity of the LHRH-agonist (Goserelin), in hormone-dependent breast cancer in dogs. The results showed that goserelin is effective in the treatment of hormone-dependent canine breast cancer, specifically acting on the hypothalamus-pituitary-ovary axis.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
